CR10388A - Composiciones antibioticas de libracion modificada y procesos para la produccion de las mismas. - Google Patents

Composiciones antibioticas de libracion modificada y procesos para la produccion de las mismas.

Info

Publication number
CR10388A
CR10388A CR10388A CR10388A CR10388A CR 10388 A CR10388 A CR 10388A CR 10388 A CR10388 A CR 10388A CR 10388 A CR10388 A CR 10388A CR 10388 A CR10388 A CR 10388A
Authority
CR
Costa Rica
Prior art keywords
libration
modified
processes
production
same
Prior art date
Application number
CR10388A
Other languages
English (en)
Inventor
Rajesh Jain
Kour Chand Jindal
Munish Talwar
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of CR10388A publication Critical patent/CR10388A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CR10388A 2006-03-24 2008-10-21 Composiciones antibioticas de libracion modificada y procesos para la produccion de las mismas. CR10388A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN824DE2006 2006-03-24

Publications (1)

Publication Number Publication Date
CR10388A true CR10388A (es) 2009-01-19

Family

ID=38540834

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10388A CR10388A (es) 2006-03-24 2008-10-21 Composiciones antibioticas de libracion modificada y procesos para la produccion de las mismas.

Country Status (16)

Country Link
US (1) US20090111788A1 (es)
EP (1) EP2001465A1 (es)
JP (1) JP2009530367A (es)
KR (1) KR20090006123A (es)
CN (1) CN101410109A (es)
AU (1) AU2007230546A1 (es)
BR (1) BRPI0709179A2 (es)
CA (1) CA2644911A1 (es)
CR (1) CR10388A (es)
EA (1) EA200870368A1 (es)
MA (1) MA30335B1 (es)
MX (1) MX2008012260A (es)
RS (1) RS20080430A (es)
TN (1) TNSN08348A1 (es)
WO (1) WO2007110875A1 (es)
ZA (1) ZA200807943B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100255099A1 (en) * 2007-10-26 2010-10-07 Rexahn Pharmaceuticals, Inc. Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
AU2008317315A1 (en) * 2007-10-26 2009-04-30 Rexahn Pharmaceuticals, Inc. Pharmaceutical formulation of clavulanic acid
US20090148532A1 (en) * 2007-12-06 2009-06-11 Venkatesh Gopi M Preparation of controlled release skeletal muscle relaxant dosage forms
WO2010038691A1 (ja) * 2008-09-30 2010-04-08 アステラス製薬株式会社 経口投与用粒子状医薬組成物
WO2011086575A2 (en) * 2010-01-13 2011-07-21 Toyochem Laboratories A pharmaceutical composition for treatment of respiratory tract infections
EP2575777A1 (en) * 2010-06-03 2013-04-10 Mahmut Bilgic Formulation comprising cefpodoxime proxetil and clavulanic acid
CN102861015B (zh) * 2011-07-05 2015-07-08 北京乐维生物技术有限公司 一种稳定的阿莫西林克拉维酸钾缓释制剂及其制备工艺
WO2014033077A1 (en) 2012-08-28 2014-03-06 Dsm Sinochem Pharmaceuticals Netherlands B.V. Composition comprising an antibiotic and a beta-lactamase inhibitor, wherein at| least one of them is in the form of mini-tablets
US9254261B2 (en) * 2014-03-03 2016-02-09 Sandoz Ag Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid
CA2944900C (en) 2014-04-04 2023-02-28 Pharmaquest International Center, LLC Disintegrating monolithic modified release tablets containing quadri-layer extended release granules
US10335374B2 (en) * 2014-12-04 2019-07-02 University System of Georgia, Valdosta State University Tablet composition for anti-tuberculosis antibiotics
EP3258918A1 (en) * 2015-02-20 2017-12-27 Cytec Industries Inc. Dialkyl sulfosuccinate compositions, method of making, and method of use
JP7370125B2 (ja) * 2018-11-09 2023-10-27 日本化薬株式会社 エルロチニブを有効成分とする医薬錠剤
JP7370124B2 (ja) * 2018-11-09 2023-10-27 日本化薬株式会社 エルロチニブを有効成分とする医薬錠剤
CN113116860B (zh) * 2021-04-22 2022-11-25 海南通用三洋药业有限公司 一种阿莫西林胶囊及其制备方法
CN113398069A (zh) * 2021-07-10 2021-09-17 四川成康动物药业有限公司 兽用阿莫西林与磺胺嘧啶钠混悬注射液及制备方法和装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9201930D0 (sv) * 1992-06-24 1992-06-24 Astra Ab Gastric antibacterial treatment
AU2001292185A1 (en) * 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles

Also Published As

Publication number Publication date
MX2008012260A (es) 2008-10-07
MA30335B1 (fr) 2009-04-01
EP2001465A1 (en) 2008-12-17
RS20080430A (en) 2009-05-06
EA200870368A1 (ru) 2009-04-28
ZA200807943B (en) 2009-11-25
TNSN08348A1 (en) 2009-12-29
BRPI0709179A2 (pt) 2011-06-28
US20090111788A1 (en) 2009-04-30
CN101410109A (zh) 2009-04-15
WO2007110875A1 (en) 2007-10-04
JP2009530367A (ja) 2009-08-27
KR20090006123A (ko) 2009-01-14
AU2007230546A1 (en) 2007-10-04
CA2644911A1 (en) 2007-10-04

Similar Documents

Publication Publication Date Title
CR10388A (es) Composiciones antibioticas de libracion modificada y procesos para la produccion de las mismas.
ATE469940T1 (de) Polyethylenzusammensetzungen, herstellungsverfahren dafür und gegenstände daraus
BRPI0815138A2 (pt) Métodos e organismos para a produção acoplada a crescimento de 1,4-butanodiol
BR112012001666A2 (pt) composições de proteína rsv f e métodos para fazer as mesmas
BRPI0718339A2 (pt) Composto, composição, composição farmacêutica e processo de fabricação de tanato de rasagilina
BRPI0820139A2 (pt) Composição antiperspirante ativa, e, processo de obtenção de uma composição antiperspirante ativa
BRPI0915749A2 (pt) métodos, composições e sistemas para produção biossintética de 1,4-butanodiol
ATE461241T1 (de) Polyurethanzusammensetzungen und daraus hergestellte gegenstände und herstellungsverfahren dafür
BRPI0810896A2 (pt) Composições de lodo particulado aquoso e métodos de produção do mesmo.
BRPI0815310A2 (pt) Composição adesiva, artigo e método de aplicação de uma composição adesiva
BRPI0717673A8 (pt) composição de oligogalacturonanas, biomaterial e têxtil
BRPI0716443A2 (pt) fibra, mÉtodo para fabricar uma fibra, e, produto de fibra
BRPI0809690A2 (pt) Composição de lubrificante, e, método
DE602007014118D1 (de) Polyethylenzusammensetzungen, herstellungsverfahren dafür und gegenstände daraus
BRPI0716881A2 (pt) Composições tópicas
BRPI0807220B1 (pt) composição, e, métodos para aumentar a força de compressão de uma composição e para aumentar a retenção de fragrância de uma composição
GT200600227A (es) Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
DE602006020302D1 (de) Leuchtkörper
BRPI0716458A2 (pt) Composição de vulcanizado
BR112012010007A2 (pt) processo para fabricação de uma composição biodegradável, composição biodegradável, artigo biodegradável e uso da composição
EP2206429A4 (en) ANTIBIOTIC COMPOSITION AND MANUFACTURING METHOD THEREFOR
BRPI0715167A2 (pt) Composição e método de desfolhante
CL2007002727A1 (es) Proceso de preparacion de anastrozol; y compuestos intermediarios.
CR10685A (es) Proceso para estabilizaciuon de famotidina
ZA200904530B (en) Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)